Akso Health (AHG) Long-Term Deferred Tax (2017 - 2026)
Akso Health (AHG) posted quarterly Long-Term Deferred Tax of $4.9 million for Q1 2026, down 88.23% year-on-year from $41.3 million in Q1 2025, and down 88.23% on a QoQ basis from $41.3 million in Q1 2025.
Akso Health (AHG) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
Akso Health (AHG) has reported Long-Term Deferred Tax for 6 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 88.23% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 88.23% YoY) and the FY2026 annual result came in at $4.9 million, down 88.23% from the prior year.
- Long-Term Deferred Tax slipped to $4.9 million in Q1 2026 per AHG's latest filing, from $41.3 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for AHG reached as high as $41.3 million in Q1 2025 and fell as low as $4.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.86 Mn |
| Mar 31, 2025 | 41.27 Mn |
| Mar 31, 2020 | 7.47 Mn |
| Sep 30, 2019 | 2.74 Mn |
| Mar 31, 2019 | 4.00 Mn |
| Dec 31, 2018 | 2.38 Mn |
| Mar 31, 2017 | 400,062.00 |